BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16424044)

  • 41. Melatonin induces calcium mobilization and influences cell proliferation independently of MT1/MT2 receptor activation in rat pancreatic stellate cells.
    Santofimia-Castaño P; Garcia-Sanchez L; Ruy DC; Sanchez-Correa B; Fernandez-Bermejo M; Tarazona R; Salido GM; Gonzalez A
    Cell Biol Toxicol; 2015 Apr; 31(2):95-110. PubMed ID: 25764371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zinc homeostasis in C6 glioma cells: phospholipase C activity regulates cellular zinc export.
    Jansen S; Arning J; Beyersmann D
    Biol Trace Elem Res; 2005; 108(1-3):87-104. PubMed ID: 16327063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells.
    Sánchez-Sánchez AM; Martín V; García-Santos G; Rodríguez-Blanco J; Casado-Zapico S; Suarez-Garnacho S; Antolín I; Rodriguez C
    Free Radic Res; 2011 Nov; 45(11-12):1333-41. PubMed ID: 21923620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiproliferative activity of melanoidins isolated from heated potato fiber (potex) in glioma cell culture model.
    Langner E; Nunes FM; Pozarowski P; Kandefer-Szerszeń M; Pierzynowski SG; Rzeski W
    J Agric Food Chem; 2011 Mar; 59(6):2708-16. PubMed ID: 21341669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression.
    Sahin A; Velten M; Pietsch T; Knuefermann P; Okuducu AF; Hahne JC; Wernert N
    Int J Mol Med; 2005 May; 15(5):771-6. PubMed ID: 15806297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.
    Ma H; Wang Z; Hu L; Zhang S; Zhao C; Yang H; Wang H; Fang Z; Wu L; Chen X
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1322-1330. PubMed ID: 29408377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.
    Tomás-Zapico C; Coto-Montes A
    J Pineal Res; 2005 Sep; 39(2):99-104. PubMed ID: 16098085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracellular second messengers involved in melatonin signal transduction in chicken splenocytes in vitro.
    Markowska M; Mrozkowiak A; Pawlak J; Skwarło-Sońta K
    J Pineal Res; 2004 Oct; 37(3):207-12. PubMed ID: 15357666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light during darkness, melatonin suppression and cancer progression.
    Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC
    Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():52-6. PubMed ID: 12163849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects and mechanisms of melatonin on the proliferation and neural differentiation of PC12 cells.
    Liu Y; Zhang Z; Lv Q; Chen X; Deng W; Shi K; Pan L
    Biochem Biophys Res Commun; 2016 Sep; 478(2):540-5. PubMed ID: 27457802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin signaling and cell protection function.
    Luchetti F; Canonico B; Betti M; Arcangeletti M; Pilolli F; Piroddi M; Canesi L; Papa S; Galli F
    FASEB J; 2010 Oct; 24(10):3603-24. PubMed ID: 20534884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling.
    Wiesenberg I; Missbach M; Carlberg C
    Restor Neurol Neurosci; 1998 Jun; 12(2-3):143-50. PubMed ID: 12671309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular redox state regulation by parthenolide.
    Herrera F; Martin V; Rodriguez-Blanco J; García-Santos G; Antolín I; Rodriguez C
    Biochem Biophys Res Commun; 2005 Jul; 332(2):321-5. PubMed ID: 15910740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.
    Parajuli P; Joshee N; Chinni SR; Rimando AM; Mittal S; Sethi S; Yadav AK
    J Neurooncol; 2011 Jan; 101(1):15-24. PubMed ID: 20467782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells.
    Martín V; Sanchez-Sanchez AM; Puente-Moncada N; Gomez-Lobo M; Alvarez-Vega MA; Antolín I; Rodriguez C
    J Pineal Res; 2014 Oct; 57(3):308-16. PubMed ID: 25163989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
    Couldwell WT; Antel JP; Yong VW
    Neurosurgery; 1992 Oct; 31(4):717-24; discussion 724. PubMed ID: 1407458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Volatile anesthetics affect the morphology of rat glioma C6 cells via RhoA, ERK, and Akt activation.
    Tas PW; Gambaryan S; Roewer N
    J Cell Biochem; 2007 Oct; 102(2):368-76. PubMed ID: 17492663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonergic system-based two-gene index is prognostic in human gliomas.
    Kinker GS; Oba-Shinjo SM; Carvalho-Sousa CE; Muxel SM; Marie SK; Markus RP; Fernandes PA
    J Pineal Res; 2016 Jan; 60(1):84-94. PubMed ID: 26510398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.
    Chen CM; Hsieh YH; Hwang JM; Jan HJ; Hsieh SC; Lin SH; Lai CY
    Tumour Biol; 2015 May; 36(5):3407-15. PubMed ID: 25527158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.
    González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
    Br J Cancer; 2007 Sep; 97(6):755-60. PubMed ID: 17700567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.